Benitec announced this week that it has appointed John Rawling as co-company secretary and accountant.
Rawling is a chartered accountant who also is currently secretary and CFO of EQiTX, an Australian biotech firm currently undergoing a restructuring. Benitec’s current CEO, Sue Macleman, was formerly the CEO of EQiTX.
Benitec also said that John Morrison has been named business development and licensing manager for the company. He was most recently a business development consultant at BioComm Services, an Australian technology management and commercial development firm.
Tapestry Pharmaceuticals said last month that it has named Donald Picker as its president.
Picker had previously been senior vice president of research and development at antisense drug firm Genta, where he helped develop the company’s now-failed cancer drug Genasense.